kidney disease glp-1 news GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog

GLP-1s are back in the news — but this is a conversation we've explored on our channel before. From weight loss to heart, kidney, liver, sleep and metabolic health, the science is

26.91

★★★★☆4.8 (126)

Did you know that a medication for diabetes may also help protect your kidneys? GLP-1 medications, known for helping with weight loss, offer surprising benefits for people with kidney disease

24.44

★★★★★4.9 (98)

GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute kidney disease

27.91

★★★★★5.0 (157)

Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology

20.65

★★★★★4.7 (84)

GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

26.63

★★★★★4.9 (203)

Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis

26.23

★★★★★5.0 (176)

Study uncovers how chronic kidney disease impacts glucose and glycemic control

27.22

★★★★★4.8 (132)